Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 27 Breast Neoplasms 23 Ovarian Neoplasms 19 Triple Negative Breast Neoplasms 17 Endometrial Neoplasms 16 Lung Neoplasms 15 Parkinson Disease 4, Autosomal Dominant Lewy Body 12 Fallopian Tube Neoplasms 11 Squamous Cell Carcinoma of Head and Neck 9 Neoplasm Metastasis 9 Neoplasms 6 Esophageal Neoplasms 6 Adenocarcinoma Of Esophagus 6 Stomach Neoplasms 4 Melanoma 4 Esophageal Squamous Cell Carcinoma 4 Cholangiocarcinoma 4 Uterine Cervical Neoplasms 3 Colorectal Neoplasms 3 Carcinoma 3 Uterine Neoplasms 2 Urinary Bladder Neoplasms 2 Peritoneal Neoplasms 2 Pathologic Complete Response 2 Head and Neck Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Ovarian Epithelial 2 Brenner Tumor 2 Anatomic Stage I Breast Cancer AJCC v8 2 Advanced Solid Tumour 2

Interventions

Taxes 1 Specimen Handling 1 Paclitaxel 1 Magnetic Resonance Spectroscopy 1 Gemcitabine 1 Endoscopic Ultrasound-Guided Fine Needle Aspiration 1 Catheter Ablation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Cystic Neoplasm × Paclitaxel × 30 days × Clear all

NCT07529483 2026-05-29

ERASE-Chemo

Ohio State University Comprehensive Cancer Center

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cystic Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon ⚡